Activinsights at Digital Biomarkers and Digital Measurements Summit

| Activinsights News

On 26-27th October, Activinsights were pleased to participate in the annual Digital Biomarkers and Digital Measurements Summit which focussed on driving digital innovation for a new age of medicine.

As a supporting Knowledge Partner, our CTO and Founder, Joss Langford, took part in a panel discussion called ‘Where Does the Future Lie for Digital Biomarkers and Digital Measurements?’.

Some of the questions discussed included:

  • What are the limitations of Digital Biomarkers? Many have been discovered for some disease states and not so many for others. Could there be cross industry collaboration?
  • How can we expand our learning so that it carries on through to successful Digital Therapeutics?
  • How can we use Digital Biomarkers and Measurements proactively to ensure early intervention before disease onset?
  • What tips would the panelists give the audience to steer Digital Biomarkers and Digital Measurements into everyday healthcare?

Joss was joined by; Peter Bergethon from Biogen, Dan Karlin from Mindmed, Shoibal Datta from Takeda, Kate Lyden, from VivoSense, and Liam Kaufman from Winterlight Labs.

If you missed the session, be sure to catch up on Vimeo below.


Watch Now

Forthcoming Events

  • Jun 2022   Decentralized Clinical Trials 2022, Florida, USA
  • Jun 2022   ICAMPAM 2022, Colorado, USA
  • Jun 2022   Digital Biomarkers & Digital Measurements Summit Europe, London, UK

View all events